Socinski, Mark A Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Apr 2003 - 91-7 p. digital Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study ISSN: 0169-5002 Standard No.: 10.1016/s0169-5002(02)00527-5 doi Subjects--Topical Terms: AdultAgedAntineoplastic Combined Chemotherapy Protocols--adverse effectsCarcinoma, Small Cell--drug therapyCisplatin--adverse effectsFemaleHumansIfosfamide--adverse effectsLung Neoplasms--drug therapyMaleMiddle AgedNeoplasm StagingPaclitaxel--adverse effectsQuality of LifeSurvival RateTaxoids